Roger Kurlander

National Institutes of Health Clinical Center — United States

Medicine · Health Sciences

38h-index6.2kcitations118works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(34), Immunotherapy and Immune Responses(27), Immune Cell Function and Interaction(26), T-cell and B-cell Immunology(24), CAR-T cell therapy research(22)

Publications117 total

SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation
PLoS ONE·2020· 5 citedOpen Access
Heat shock proteins stimulate APOBEC-3–mediated cytidine deamination in the hepatitis B virus
Journal of Biological Chemistry·2017· 26 citedOpen Access
A Naive NK Cell Repertoire in the Circulation of Haploidentical Stem Cell Donors Pre Mobilization Predicts Rejection of Cord Myeloid Cells in Patients Undergoing Combined Haploidentical and Unrelated Cord Blood HSCT
Blood·2016
Excellent Outcomes of Combined Haploidentical and Cord-Blood (Haplo-Cord) Transplantation and HLA-Matched Sibling (Matched-Sib) Donor Transplantation for High-Risk Patients with Severe Aplastic Anemia (SAA) Refractory to Immunosuppressive Therapy
Blood·2016· 4 cited
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
Journal of Clinical Oncology·2016· 596 citedOpen Access
Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome
Allergy·2016· 53 citedOpen Access
Allogeneic T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation without Causing Graft-Versus-Host Disease
Blood·2015· 5 cited
Excellent Engraftment and Long-Term Survival in Patients with Severe Aplastic Anemia (SAA) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Haplo-Identical CD34+ Cells Combined with a Single Umbilical Cord Blood Unit
Blood·2015· 3 cited
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Journal of Molecular Diagnostics·2015· 46 citedOpen Access
Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor
Journal of Hematology & Oncology·2015· 20 citedOpen Access
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Clinical Cancer Research·2015· 11 citedOpen Access
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Biology of Blood and Marrow Transplantation·2015Open Access
Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities
Blood·2014· 15 cited
Clinical and biological predictors of outcome following relapse of CML post-allo-SCT
Bone Marrow Transplantation·2014· 7 citedOpen Access
T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute Gvhd after Low-Intensity Allogeneic HCT
Biology of Blood and Marrow Transplantation·2014· 1 cited
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Leukemia Research·2013· 95 cited
Differences in the Phenotype, Cytokine Gene Expression Profiles, and In Vivo Alloreactivity of T Cells Mobilized with Plerixafor Compared with G-CSF
The Journal of Immunology·2013· 38 citedOpen Access
Evaluation Of Circulating Cell-Free VDJ DNA As a Marker For Monitoring Patients With Multiple Myeloma (MM) During Treatment With Carfilzomib, Lenalidomide and Dexamethasone,
Blood·2013· 1 cited
Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone
Blood·2013
NK Cell KIR Ligand Mismatches Influence Engraftment Following Combined Haploidentical and Umbilical Cord Blood (UCB) Transplantation In Patients With Severe Aplastic Anemia (SAA)
Blood·2013· 6 cited
page 1 of 6Next →

Frequent Co-authors

Richard Childs(10), Bipin N. Savani(10), Stephan Mielke(8), Tatyana G. Vishnyakova(8), Alexander V. Bocharov(8), Amy P. Patterson(8), Irina N. Baranova(7), Thomas L. Eggerman(7), A. John Barrett(7), Katayoun Rezvani(6), György Csákó(6), Agnes S. M. Yong(6), Abdul Tawab(5), Alan T. Remaley(5), Elizabeth J. Read(5), Aldemar Montero(4), Nancy F. Hensel(4), A. John Barrett(4), Nancy L. Geller(4), David S. Pisetsky(3)